Indication

Collatamp G is used for local haemostasis of capillary, parenchymatous and seeping haemorrhages in areas with a high risk of infection (determined by the surgeon on a case-by-case basis, including patient-related, surgery related, and physiological factors).¹

This product contains gentamicin sulphate at a locally effective dose.¹
After implantation of Collatamp G, systemic gentamicin plasma amounts may temporarily reach therapeutic levels.¹

Properties

Haemostasis is triggered when blood comes into contact with released tissue factors and exposed endogenous collagen fibrils or renatured collagen fibrils like those in Collatamp G. The adhesion and aggregation of platelets is induced on the renatured collagen fibrils of Collatamp G and the plasmatic coagulation process is accelerated.¹

The sponge-like structure of Collatamp G stabilises the wound clot and takes up a certain amount of blood. Collagen also promotes granulation and epithelialisation.¹

Collatamp G is completely absorbed (estimated that in the overwhelming majority of cases, Collatamp G is completely or predominantly degraded within 4-8 weeks, regardless of the site of implantation). The gentamicin included in Collatamp G helps to prevent infections that might occur at the site of implantation caused by gentamicin-sensitive bacteria. The administration of Collatamp G might not prevent an infection with gentamicin-resistant bacteria. The risk of infection is based on individual/combination of factors.¹

Composition

Collatamp G is a sterile fully absorbable haemostatic device for implantation. It is composed of bovine collagen incorporating gentamicin sulfate at a locally effective dose. The product is available in three different sizes.¹